Document is current
Any future updates will be listed below
-
Authors
An, Tai Joon https://orcid.org/0000-0002-0286-2638
Lee, Jangwon https://orcid.org/0000-0001-9626-282X
Shin, Myoungin https://orcid.org/0000-0003-3456-8123
Yoo, Kwang Ha https://orcid.org/0000-0001-9969-2657
Hwang, Yong Il https://orcid.org/0000-0002-3502-5211
Min, Kyung Hoon https://orcid.org/0000-0003-0610-2182
Kim, Deog Kyeom https://orcid.org/0000-0001-9379-8098
Sim, Yun Su https://orcid.org/0000-0002-3746-4947
Jung, Ji Ye https://orcid.org/0000-0003-1589-4142
Rhee, Chin Kook https://orcid.org/0000-0003-4533-7937
,
-
Funding
Funding for this research was provided by:
Korea Ministry of Environment (2022003310008)
- License Information
-
More Information
Article History
Received: 2 January 2024
Accepted: 19 September 2024
First Online: 27 September 2024
Declarations
:
: This study was approved and informed consent was waived due to its anonymization (KINRESS) and retrospective nature of multicenter data (retrospective cohort) by the Institutional Review Board of the Catholic University of Korea Yeouido St. Mary’s Hospital (approval number SC23ZISE0002).
: All authors agreed with publication.
: CK Rhee received consulting/lecture fees from MSD, AstraZeneca, GSK, Novartis, Takeda, Mundipharma, Boehringer-Ingelheim, Teva, Sanofi, and Bayer. Other authors did not have any conflicts of interest to declare.
